Oncology Innovative Products
Weembrace Biopharma offers a broad range of Oncology pharmaceuticals and nutraceuticals backed by continuous research and innovation. Our portfolio includes solid , hard and soft capsules, lyophilised lipid suspensions, and ready-to-use injectable formulations and introduction of the latest interventions related to the innovative supportive care solutions for chemotherapy- and radiotherapy-associated oral mucositis. We focus on efficacy, safety, and product stability to support better patient care. As an emerging oncology focused company, we are committed to making advanced, accessible cancer care a reality. With our vision “Smile with Miles,” we strive to bring hope and support patient well-being during treatment.
| Brand Name | Molecule | Therapy | Dosage Form | Packing | Package Insert |
|---|---|---|---|---|---|
| DOCISOL 20MG /80MG | Nanosomal Docetaxel lipid Suspension | Anti-neoplastic | Vial | 1x20mg, 1X80mg |
Download PDF |
| XELODACE DT 1GM /500MG | Capecitabine | Anti-neoplastic | Dispersible Tablet | 1X10’s |
Download PDF |
| WEMBIRA DT 250MG | Abiraterone acetate | Anti-neoplastic | Dispersible Tablet | 1X10’s |
Download PDF |
| ABRA ACE 100 MG | Paclitaxel (protein-bound particle) for Injectable Suspension | Anti-neoplastic | Vial | 1X100mg |
Download PDF |
| LEVISCD2 | Levilactobacillus brevis CD2 | Probiotic | Lozenges | 1X20’s |
Download PDF |
*Disclaimer: The information provided on this page is intended for informational purposes only and should not be construed as medical advice, diagnosis, or treatment recommendation. Users are advised to consult qualified healthcare professionals where applicable.